Results 221 to 230 of about 783,324 (285)

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 888-899, April 2025.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki, Tetsu Watanabe, Mari Shimizu, Shingo Tachibana, Junya Sato, Yuta Kobayashi, Harutoshi Tamura, Shigehiko Kato, Satoshi Nishiyama, Hiroki Takahashi, Takanori Arimoto, Masafumi Watanabe   +11 more
wiley   +1 more source

The N-terminus of apolipoprotein B mediates the interaction of atherogenic lipoproteins with endothelial cells. [PDF]

J Clin Invest
Cabodevilla AG, Calistru C, Younis W, Nasias D, Ho TW, Anaganti N, Valmiki S, Rajan S, Gjini J, Kore R, Hannemann C, Davidson NO, Vaisar T, Kanter JE, Bornfeldt KE, Fisher EA, Lee WL, Madl T, Hussain MM, Goldberg IJ.   +19 more
europepmc   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Promotion of hepatitis B virus infection by extracellular apolipoprotein E. [PDF]

J Virol
Elgendy E, Tripathi SK, Luo G.
europepmc   +1 more source

Cholesterol at the Center of Alzheimer's Disease: A Unifying Hypothesis on the Pathogenic Mechanism. [PDF]

Molecules
Zhu BT.
europepmc   +1 more source

LR11/SorLA and its role in cardiovascular disease. [PDF]

Int J Cardiol Heart Vasc
Kloosterman M, Vongpromek R, Friesema ECH, Bramer W, Verhoeven AJM, Mulder MT.   +5 more
europepmc   +1 more source

Cardiac Lipid Metabolism: Cells, Metabolites, and Rhythms. [PDF]

Circ Res
Goldberg IJ, Young ME, Schulze PC, Drosatos K.   +3 more
europepmc   +1 more source

Microbial mechanisms in atherosclerosis: Revisiting the infectious hypothesis. [PDF]

Atheroscler Plus
El Hayek C, Kahkedjian F, Amin G, Booz GW, Zouein FA.   +4 more
europepmc   +1 more source

Leveraging endogenous proteins to improve cancer nanomedicine delivery.

Nanoscale
Xu Z, Jolly KJ, Zhang F.
europepmc   +1 more source